€
4. 83
+0.11
+2.3305%
€
- Market Cap
- P/E Ratio
- Div Yield
450 Volume
- Eps
€ 4.72
Previous Close Want to track 8IM1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Implantica AG (8IM1) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.47B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 17.53
Enterprise Value/Revenue 708.25
Enterprise Value/EBITDA -72.48
Overview
Shares outstanding -
Float 7.6M
Shares short -
% Held by insiders -
% Held by institutions 0.12%
Average volume (10 days) 1.69K
Average volume (90 days) 1.56K
Price summary
52-Week low 3.62
52-Week high 7.15
Beta 0.77
50-Day moving average 4.11
200-Day moving average 4.78
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -13.95%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.22%
Income Statement
Revenue (ttm) 2.07M
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) 0.2%
Gross profit (ttm) -549K
EBITDA -20.26M
Net income to common (ttm) -19.63M
Diluted EPS (ttm) -0.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 19.86M
Total cash per share (mrq) 0.07
Total debt (mrq) 209K
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 17.8%
Book value per share (mrq) 0.3
Cash Flow
Cash flow statement -16.56M
Levered free cash flow (LFCF) -10.64M
